Choline forms and memory tests

Comparison of bitartrate, lysolecithin and citicoline in separate memory tests.

Key points

  • In healthy adults aged 18–29, a single dose of choline bitartrate showed no advantage over placebo on the three memory tests studied. This acute comparison does not support expecting a confirmed improvement in these memory measures. [1] See the evidence 1 2 3
  • In adults aged 50–85 with age-related memory complaints, citicoline showed no advantage on the primary test over 12 weeks, although a secondary episodic memory test improved. For people with similar age-related complaints there is a preliminary signal of a better result on a specific secondary paired-associates test. [2] See the evidence 1 2
  • In adults aged 40–74, lysolecithin showed no advantage over placebo in general memory over eight weeks. Based on this comparison, a confirmed improvement in general memory should not be expected when choosing lysolecithin. [3] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Different forms and memory tests were studied in different groups and regimens.

Key points

Why these conclusions

Different forms and results

In healthy adults aged 18–29, a single 2.5 g dose of choline bitartrate in juice, containing about 1 g choline, showed no advantage in spatial or verbal working memory or declarative recall. [1]

In adults aged 40–74, lysolecithin containing 480 mg lysophosphatidylcholine per day showed no advantage in general memory over eight weeks. [3]

In adults aged 50–85 with age-related memory complaints, 500 mg citicoline per day showed no advantage on the primary spatial test over 12 weeks. Improvement in the secondary paired-associates test was greater than with placebo. [2]

Choline is an essential nutrient. Bitartrate, phosphatidylcholine, lysolecithin, citicoline and α-GPC have different compositions and amounts of elemental choline; results for one form do not transfer to another. [4] [3] [2] [5]

A single dose of choline bitartrate showed no advantage in spatial working memory.

ParameterData
ResultA single dose of choline bitartrate showed no advantage in spatial working memory. Bitartrate 70±18% versus 72±16%, p=0.630; no advantage found.
ParticipantsHealthy adults aged 18–29; 40 began experiment 3, 37 completed it
FormCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
DoseCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
Dose basisCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
ComparatorPlacebo
DurationSingle dose in each phase, one-week interval
Confidence2/4: Precision: small sample and no CI for the difference.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: the comparison directly addresses the stated research question.; Possible publication bias: no data for a separate downgrade.; Study methods: few losses and limited description of analysis procedures.
Evidence base1 trial
Sources[1]

A single dose of choline bitartrate showed no advantage in declarative recall.

ParameterData
ResultA single dose of choline bitartrate showed no advantage in declarative recall. Bitartrate 71±15% versus 72±11%, p=0.489; no advantage found.
ParticipantsHealthy adults aged 18–29; 40 began experiment 3, 37 completed it
FormCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
DoseCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
Dose basisCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
ComparatorPlacebo
DurationSingle dose in each phase, one-week interval
Confidence2/4: Precision: small sample and no CI for the difference.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: the comparison directly addresses the stated research question.; Possible publication bias: no data for a separate downgrade.; Study methods: few losses and limited description of analysis procedures.
Evidence base1 trial
Sources[1]

A single dose of choline bitartrate showed no advantage in verbal working memory.

ParameterData
ResultA single dose of choline bitartrate showed no advantage in verbal working memory. Bitartrate 35±20 versus 35±19, p=0.987; no advantage found.
ParticipantsHealthy adults aged 18–29; 40 began experiment 3, 37 completed it
FormCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
DoseCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
Dose basisCholine bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally
ComparatorPlacebo
DurationSingle dose in each phase, one-week interval
Confidence2/4: Precision: small sample and no CI for the difference.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: the comparison directly addresses the stated research question.; Possible publication bias: no data for a separate downgrade.; Study methods: few losses and limited description of analysis procedures.
Evidence base1 trial
Sources[1]

Lysolecithin showed no advantage in general memory over eight weeks.

ParameterData
ResultLysolecithin showed no advantage in general memory over eight weeks. WMS-R general memory: 100.8→110.7 versus 108.5→115.2; no significant between-group difference.
Participants46 adults aged 40–74, 23 and 22 analyzed
FormLysolecithin orally, 480 mg lysophosphatidylcholine per day
DoseLysolecithin orally, 480 mg lysophosphatidylcholine per day
Dose basisLysolecithin orally, 480 mg lysophosphatidylcholine per day
ComparatorPlacebo
Duration8 weeks
Confidence2/4: Precision: 45 analyzed and no CI for the effect.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: the comparison directly addresses the stated research question.; Possible publication bias: no data for a separate downgrade.; Study methods: marked baseline memory imbalance makes changes difficult to assess.
Evidence base1 trial
Sources[3]

Citicoline showed no advantage on the primary spatial memory test over 12 weeks.

ParameterData
ResultCiticoline showed no advantage on the primary spatial memory test over 12 weeks. Spatial Span: 4.65→4.90 versus 4.75→4.67; no between-group advantage on the primary outcome.
Participants100 adults aged 50–85 with age-related memory complaints, 99 completed
FormCiticoline orally 500 mg/day
DoseCiticoline orally 500 mg/day
Dose basisCiticoline orally 500 mg/day
ComparatorPlacebo
Duration12 weeks
Confidence2/4: Precision: one RCT; the extracted data do not report the CI for the contrast.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: the comparison directly addresses the stated research question.; Possible publication bias: no data for a separate downgrade.; Study methods: industry funding and incomplete quantitative reporting of the primary contrast.
Evidence base1 trial
Sources[2]

On a secondary episodic memory test the score improved by 0.15 versus 0.06 points with placebo.

ParameterData
ResultOn a secondary episodic memory test the score improved by 0.15 versus 0.06 points with placebo. Paired Associates change +0.15 versus +0.06; p=0.0025 after adjustment for multiple comparisons.
Participants100 adults aged 50–85 with age-related memory complaints, 99 completed
FormCiticoline orally 500 mg/day
DoseCiticoline orally 500 mg/day
Dose basisCiticoline orally 500 mg/day
ComparatorPlacebo
Duration12 weeks
Confidence1/4: Precision: one RCT without an exact CI for the contrast in the extraction.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: a laboratory test does not measure preservation of daily function.; Possible publication bias: no data for a separate downgrade.; Study methods: secondary outcome in a test battery.
Evidence base1 trial
Sources[2]

Choline is an essential nutrient. Bitartrate, phosphatidylcholine, lysolecithin, citicoline and α-GPC have different compositions and amounts of elemental choline; results for one form do not transfer to another.

Choline is an essential nutrient. Bitartrate, phosphatidylcholine, lysolecithin, citicoline and α-GPC have different compositions and amounts of elemental choline; results for one form do not transfer to another. [4] [3] [2] [5]

More details

How to compare results

The preliminary signal concerns a secondary citicoline test and the specified group; results of different forms do not automatically transfer to one another. [2] [4]

Sources

  1. No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults. https://doi.org/10.1371/journal.pone.0157714
  2. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC8349115/
  3. Effects of an 8-week intake of lysolecithin on cognitive function and concentrations of blood choline and lysophosphatidylcholine: a randomized, double-blinded, placebo-controlled trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC11782770/
  4. NIH ODS Choline Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Choline-HealthProfessional/
  5. Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. https://pmc.ncbi.nlm.nih.gov/articles/PMC5629791/

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Choline